The phrase "a source of molecular" is correct and usable in written English.
It can be used in scientific or technical contexts when discussing origins or providers of molecular substances or components.
Example: "The laboratory serves as a source of molecular compounds for various research projects."
Alternatives: "a provider of molecular" or "an origin of molecular".
Indeed, benzene is a molecule that is surprisingly resistant to chemical attack (double bonds, rather than being a source of molecular strength and stability, are usually the targets of chemical attack) and is more stable than its structure suggests.
Without direct experimental data, it is difficult to place P. carinii within its proper category, but assuming it cannot grow without a source of molecular oxygen, it would seem to be either an obligate respirer or perhaps a facultative aerobic fermenter, depending on the function of its alcohol dehydrogenases.
These gene sequences are candidate regulators of wood formation and could be a source of molecular markers for tree breeding related to wood properties.
The close linkage of the MtNIP3 locus to B toxicity tolerance provides a source of molecular selection tools to pasture breeding programs.
Further investigation is necessary for a more detailed evaluation of the copy number, transpositional activity, and insertional polymorphism of the TEs, including MITEs, as they could be utilized as a source of molecular markers.
The insertion polymorphism of the MtPH elements and related MITE families in different populations of M. truncatula, if further confirmed experimentally, could be used as a source of molecular markers complementary to other marker systems.
The second fraction containing substances below 10 kDa was used as a source of low molecular weight metabolites (extracellular low molecular weight subfraction, ex-LMS).
Urine is a non-invasively collected biospecimen that has been relatively under-represented as a source of potential molecular biomarkers of lung cancer.
Furthermore, this detailed microarray analysis generated a source of novel molecular targets for the treatment of HPV-associated diseases and potentially of non-HPV neoplasias.
Therefore, the placenta is a source of integrated molecular information about the developmental life history of the fetus and its environmental interactions.
Molecular tools are increasingly used to develop these areas of knowledge, and here we take a comparative mitogenomic approach to evaluate mitochondrial (mt) DNAs as a source of new molecular markers.
